dihydroxyphenylalanine and norbinaltorphimine

dihydroxyphenylalanine has been researched along with norbinaltorphimine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LaVigne, SD; Lookingland, KJ; Manzanares, J; Moore, KE; Wagner, EJ1
LaVigne, SD; Lookingland, KJ; Manzanares, J; Moore, KE1
Durham, RA; Johnson, JD; Lookingland, KJ; Moore, KE1

Other Studies

3 other study(ies) available for dihydroxyphenylalanine and norbinaltorphimine

ArticleYear
Sexual differences in kappa opioid receptor-mediated regulation of tuberoinfundibular dopaminergic neurons.
    Neuroendocrinology, 1992, Volume: 55, Issue:3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Arcuate Nucleus of Hypothalamus; Dihydroxyphenylalanine; Dopamine; Female; Male; Median Eminence; Naltrexone; Narcotic Antagonists; Neurons; Orchiectomy; Ovariectomy; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Sex Characteristics; Tuber Cinereum

1992
Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist NOR-binaltorphimine.
    Life sciences, 1991, Volume: 48, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hydrazines; Injections, Intraperitoneal; Male; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Pituitary Gland; Pituitary Gland, Posterior; Rats; Receptors, Opioid, kappa

1991
Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
    Brain research, 1996, Sep-02, Volume: 732, Issue:1-2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Afferent Pathways; Analgesics; Animals; Cerebral Ventricles; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Agonists; Dynorphins; Hypothalamus; Hypothalamus, Middle; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Median Eminence; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Prolactin; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Opioid, kappa

1996